受强制性开放获取政策约束的文章 - Kevin G Thompson了解详情
可在其他位置公开访问的文章：4 篇
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
强制性开放获取政策： Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health, UK …
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
强制性开放获取政策： Bill & Melinda Gates Foundation, UK Medical Research Council, National …
Cockroach allergen component analysis of children with or without asthma and rhinitis in an inner-city birth cohort
A Pomés, J Glesner, A Calatroni, CM Visness, RA Wood, GT O'Connor, ...
Journal of Allergy and Clinical Immunology 144 (4), 935-944, 2019
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定